MDS Foundation logo
Molecular International Prognostic Scoring System Developed for Myelodysplastic Syndromes
June 12, 2022 10:00 ET | MDS Foundation, Inc. (963786)
YARDVILLE, N.J., June 12, 2022 (GLOBE NEWSWIRE) -- Today, the MDS Foundation announced the development of a new prognostic scoring system, the IPSS-Molecular, that will significantly improve risk...